$512 Million is the total value of VR Adviser, LLC's 25 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 80.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COGT | Buy | COGENT BIOSCIENCES INC | $52,708,902 | +12.9% | 4,884,977 | +21.0% | 10.29% | +30.9% |
| New | ENLIVEN THERAPEUTICS INC | $48,489,710 | – | 2,214,142 | +100.0% | 9.47% | – | |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $38,038,000 | +82.2% | 1,430,000 | +32.4% | 7.43% | +111.2% |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $29,423,307 | – | 3,298,577 | +100.0% | 5.74% | – |
| AVTE | Buy | AEROVATE THERAPEUTICS INC | $16,820,308 | -23.2% | 833,927 | +11.5% | 3.28% | -11.0% |
| CABA | Buy | CABALETTA BIO INC | $16,318,786 | -6.9% | 1,973,251 | +4.1% | 3.19% | +7.9% |
| New | THESEUS PHARMACEUTICALS INC | $6,837,600 | – | 770,000 | +100.0% | 1.34% | – | |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $3,725,218 | +14.4% | 1,307,094 | +192.2% | 0.73% | +32.4% |
| New | AVALO THERAPEUTICS INC | $1,750,000 | – | 1,000,000 | +100.0% | 0.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.